findmyKOL
Clinical trialNCT05548296RecruitingPhase 2Interventional

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

SponsorAcrivon TherapeuticsEnrollment350Endometrial Adenocarcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

91 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Centre François Baclesse

    Caen, France

    Florence Joly-Lobbedez, MD
    Recruiting
  • Centre Léon Bérard

    Lyon, France

    Isabelle Ray-Coquard, MD
    Recruiting
  • Insitute de Cancérologie de L'Ouest

    Saint-Herblain, France

    Jean-Sebastien Frenel, MD
    Recruiting
  • Institute Gustave Roussy

    Villejuif, France

    Alexandra Leary, MD
    Recruiting
Germany
  • Kem | Evang. Kliniken Essen-Mitte

    Essen, Germany

    Philipp Harter, MD
    Not, yet, recruiting
  • Universitätsklinikum Münster, Klinik Für Frauenheilkunde Und Geburtshilfe

    Münster, Germany

    Lars Hanker, MD
    Not, yet, recruiting
  • Universitätsklinikum Ulm, Frauenheilunde Und Geburtshilfe

    Ulm, Germany

    Sabine Heublein, MD
    Not, yet, recruiting
Italy
  • Cro Aviano

    Aviano, Italy

    Michele Bartoletti, MD
    Not, yet, recruiting
  • Istituto Clinico Cannizzaro Catania

    Catania, Italy

    Giuseppa Scandurra, MD
    Not, yet, recruiting
  • Istituto Europeo Di Oncologia

    Milan, Italy

    Nicoletta Colombo, MD
    Not, yet, recruiting
  • Fondazione Pascale Istituto Tumori

    Naples, Italy

    Carmela Pisano, MD
    Not, yet, recruiting
  • Humanitas University

    Pieve Emanuele, Italy

    Domenica Lorusso, MD
    Not, yet, recruiting
  • Policlinico Gemelli

    Roma, Italy

    Anna Fagotti, MD
    Not, yet, recruiting
  • Ospedale Mauriziano Torino

    Turin, Italy

    Giorgio Valabrega, MD
    Not, yet, recruiting
Spain
  • Hospital Clínic de Barcelona

    Barcelona, Spain

    Lydia Gaba Garcia, MD
    Recruiting
  • Hospital Universitario Puerta de Hierro

    Barcelona, Spain

    Ana Oaknin Benzaquen, MD
    Not, yet, recruiting
  • Institut Català of Oncology (ico)

    Barcelona, Spain

    Marta Gil-Martin, MD
    Not, yet, recruiting
  • Vall D'Hebron Institute of Oncology (vhio)

    Barcelona, Spain

    Lorena Farinas, MD
    Recruiting
  • Hospital Universitario 12 de Octubre

    Madrid, Spain

    Luis Manuel Manso Sanchez, MD
    Not, yet, recruiting
  • Hospital Universitario la Paz

    Madrid, Spain

    Andrés Redondo Sanchez, MD
    Not, yet, recruiting
  • Hospital Universitario Ramón Y Cajal

    Madrid, Spain

    Eva María Guerra Alia, MD
    Not, yet, recruiting
  • Fundacion Instituto Valenciano de Oncologia (ivo)

    Valencia, Spain

    Ignacio Romero Noguera, MD
    Not, yet, recruiting
United States
  • University of South Alabama Mitchell Cancer Institute

    Mobile, Alabama, United States

    Completed
  • Alaska Women'S Cancer Center

    Anchorage, Alaska, United States

    Completed
  • Honorhealth

    Phoenix, Arizona, United States

    Lyndsay Willmott, MD
    Recruiting
  • Arizona Oncology Associate, Pc- Hope

    Tucson, Arizona, United States

    Active, not recruiting
  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas, United States

    Heather Williams, MD
    Recruiting
  • City of Hope National Medical Center

    Duarte, California, United States

    Mihae Song, MD
    Recruiting
  • Uc San Diego Moores Cancer Center

    La Jolla, California, United States

    Ramez Eskander, MD
    Recruiting
  • Cedars Sinai Medical Center

    Los Angeles, California, United States

    Emily Pendergast, MD
    Recruiting
  • Usc/norris Comprehensive Cancer Center

    Los Angeles, California, United States

    Completed
  • Hoag Cancer Center

    Newport Beach, California, United States

    Alberto Mendivil, MD
    Recruiting
  • Uc Irvine Health

    Orange, California, United States

    Completed
  • Stanford Cancer Center

    Palo Alto, California, United States

    Kirstin Bixel, MD
    Recruiting
  • University of California, Davis Comprehensive Cancer Center

    Sacramento, California, United States

    Hui Chen, MD
    Recruiting
  • University of California Los Angeles (ucla)

    Santa Monica, California, United States

    Alexandra Drakaki, MD
    Recruiting
  • University of Colorado

    Aurora, Colorado, United States

    Lindsay Brubaker, MD
    Recruiting
  • Yale Cancer Center

    New Haven, Connecticut, United States

    Completed
  • Florida Gynecologic Oncology/regional Cancer Center

    Fort Myers, Florida, United States

    Completed
  • Mount Sinai Comprehensive Cancer Center

    Miami Beach, Florida, United States

    Brian Slomovitz, MD
    Recruiting
51 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Aug 2022
Primary completion
30 May 2027
Completion
30 Nov 2027
Last update posted
15 Jun 2026
Registered enrollment
350
Registry id
NCT05548296

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.